Nominal 
[ET Net News Agency, 13 August 2026] TEDA BIOMEDICAL (08189) rose 66.7% to HK$0.25.
It hits an intra-day high of HK$0.275, hitting an 1-month high, breaking above the 100-D SMA of HK$0.225, and an intra-day low of HK$0.156. The total shares traded was 4.06 million, with a value of HK$733,075. The active buy/sell ratio is 86:14, with net buying turnover of HK$511,605. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying turnover of HK$31,500, with volume weighted average price of HK$0.18. FUTU SEC INT'L accounts for greatest net responsive selling turnover of HK$286,896, with volume weighted average price of HK$0.181. The stock has risen a combined 89.4% over the past 3 consecutive trading days.
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is 86:14, with net buying turnover of HK$511,605, rising a combined 89.4% over the past 3 consecutive trading days
(ed)
It hits an intra-day high of HK$0.275, hitting an 1-month high, breaking above the 100-D SMA of HK$0.225, and an intra-day low of HK$0.156. The total shares traded was 4.06 million, with a value of HK$733,075. The active buy/sell ratio is 86:14, with net buying turnover of HK$511,605. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying turnover of HK$31,500, with volume weighted average price of HK$0.18. FUTU SEC INT'L accounts for greatest net responsive selling turnover of HK$286,896, with volume weighted average price of HK$0.181. The stock has risen a combined 89.4% over the past 3 consecutive trading days.
| Nominal | 0.250 | % Chg | +66.67% |
| High | 0.275 | Low | 0.156 |
| Shares Tr | 4.06m | Turnover | 733,075 |
| 10-D SMA | 0.156 | %H.V | 68.163 |
| 20-D SMA | 0.150 | VWAP | 0.181 |
| 50-D SMA | 0.163 | RSI14 | 85.442 |
(ed)
